CI
AXDX

Chartist Inc’s Accelerate Diagnostics AXDX Stock Holding History

Chartist Inc’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-68,996
Closed -$270K – 28
2023
Q4 		$270K Buy
68,996
+1,923
+3% +$10.2K 0.15% 23
2023
Q3 		$386K Buy
+67,073
New +$451K 0.23% 15
2023
Q2 		– Sell
-6,587
Closed -$65.4K – 27
2023
Q1 		$65.4K Buy
+6,587
New +$39.6K 0.06% 22
2022
Q2 		$65.4K Buy
+6,587
New +$58.2K 0.04% 23
2022
Q1 		– Sell
-6,587
Closed -$344K – 34
2021
Q4 		$344K Buy
6,587
+110
+2% +$6.12K 0.15% 28
2021
Q3 		$378K Hold
6,477
– – 0.18% 23
2021
Q2 		$522K Buy
+6,477
New +$515K 0.24% 20
2019
Q4 		$1.09M Hold
6,477
– – 0.67% 8
2019
Q3 		$1.2M Hold
6,477
– – 0.78% 7
2019
Q2 		$1.48M Hold
6,477
– – 0.94% 6
2019
Q1 		$1.36M Hold
6,477
– – 1.14% 5
2018
Q4 		$745K Hold
6,477
– – 1.44% 6
2018
Q3 		$1.49M Hold
6,477
– – 0.65% 6
2018
Q2 		$1.44M Hold
6,477
– – 0.65% 6
2018
Q1 		$1.48M Hold
6,477
– – 0.69% 6
2017
Q4 		$1.7M Hold
6,477
– – 0.75% 6
2017
Q3 		$1.45M Hold
6,477
– – 0.68% 6
2017
Q2 		$1.77M Hold
6,477
– – 0.86% 6
2017
Q1 		$1.57M Hold
6,477
– – 0.77% 6
2016
Q4 		$1.34M Buy
6,477
+230
+4% +$54.6K 0.69% 6
2016
Q3 		$1.7M Hold
6,247
– – 0.89% 6
2016
Q2 		$899K Buy
+6,247
New +$838K 0.48% 10
2015
Q4 		$837K Buy
3,894
+1,700
+77% +$310K 0.41% 11
2015
Q3 		$365K Buy
2,194
+1
+0% +$216 2.24% 10
2015
Q2 		$561K Hold
2,193
– – 0.27% 36
2015
Q1 		$484K Hold
2,193
– – 0.23% 37
2014
Q4 		$417K Buy
2,193
+15
+0.7% +$3.21K 0.19% 41
2014
Q3 		$527K Sell
2,178
-27
-1% -$5.25K 0.28% 38
2014
Q2 		$564K Buy
2,205
+132
+6% +$28.8K 0.28% 40
2014
Q1 		$371K Hold
2,073
– – 0.2% 39
2013
Q4 		$242K Hold
2,073
– – 0.13% 46
2013
Q3 		$274K Buy
2,073
+153
+8% +$13.7K 0.16% 40
2013
Q2 		$157K Buy
+1,920
New +$143K 0.09% 48

Other funds holding AXDX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $1.88B AUM 21.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Chartist Inc's AXDX Position: Q1 2024 in Review

Chartist Inc sold out of Accelerate Diagnostics (AXDX) in Q1 2024, closing a stake of 68,996 shares — an estimated $270K sold.

Chartist Inc first reported a position in AXDX in Q2 2013 and held it in 33 quarters. The position peaked at $1.77M in Q2 2017. 46 funds tracked by Wall St. Rank hold AXDX as of Q1 2024.

  • Chartist Inc reported no remaining Accelerate Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Chartist Inc sold 68,996 Accelerate Diagnostics shares in Q1 2024, an estimated $270K.
  • Chartist Inc first reported a position in Accelerate Diagnostics in Q2 2013 and held it in 33 quarters.
  • Chartist Inc's Accelerate Diagnostics position peaked at $1.77M in Q2 2017.
  • 46 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2024.

Based on Chartist Inc's 13F filing for Q1 2024, filed 14 May 2024.